2011, Number 2
Case report: Fanconi syndrome associated with toxicity by tenofovir
Arellano-Contreras D, Carmona-Guzmán C
Language: Spanish
References: 9
Page: 116-119
PDF size: 823.96 Kb.
ABSTRACT
40-years-old male with Human Immunodeficiency Virus (HIV) undertaking retroviral treatment of embricitabine/tenofovir disoproxil fumarate (TDF/FTC) and lopinavir/ritonavir (LOP/r) since 2007. The patient attends the appointment without any important findings after the exploration. However, displays the following alterations on the laboratory tests: hyperchloremic metabolic acidosis with anion gap (AG), elevated urine anion gap (urinary AG), normoglycaemic glycosuria, proteinuria, low HCO3, low PO4, all findings consistent with fanconi syndrome. An ultrasonogram showed undetermined nephropathy and a biopsy spots chronic tubulo-interstitial nephritis with secondary glomerular damage. The fanconi syndrome is a generalized defect of the proximal re-absorption and the transportation of aminoacids, glucose, phosphate, uric acid, Na, K, HCO3, low molecular weight, secondary to basolateral membrane damage of Na active transportation. It may be idiopathic, secondary to systemic diseases or the use of medications. The clinical presentation includes a wide range of alterations in the laboratory exams that may be accompanied by entities such as rachitism, osteomalacia or osteoporosis. As for the glomerular damage for the use of TDF, there is evidence of physiological mechanisms. Nevertheless, the etiology is still considered as multifactorial.REFERENCES